135 related articles for article (PubMed ID: 17714437)
21. Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.
Riese MJ; Barbieri JT
Infect Immun; 2002 Apr; 70(4):2230-2. PubMed ID: 11895993
[TBL] [Abstract][Full Text] [Related]
22. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.
Angus AA; Evans DJ; Barbieri JT; Fleiszig SM
Infect Immun; 2010 Nov; 78(11):4500-10. PubMed ID: 20732998
[TBL] [Abstract][Full Text] [Related]
23. Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS.
Deng Q; Barbieri JT
Traffic; 2008 Nov; 9(11):1948-57. PubMed ID: 18778330
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an ExoS Type III translocation-resistant cell line.
Rucks EA; Olson JC
Infect Immun; 2005 Jan; 73(1):638-43. PubMed ID: 15618208
[TBL] [Abstract][Full Text] [Related]
25. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
[TBL] [Abstract][Full Text] [Related]
26. Rac2 is a major actor of Drosophila resistance to Pseudomonas aeruginosa acting in phagocytic cells.
Avet-Rochex A; Perrin J; Bergeret E; Fauvarque MO
Genes Cells; 2007 Oct; 12(10):1193-204. PubMed ID: 17903178
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases.
Ganesan AK; Mende-Mueller L; Selzer J; Barbieri JT
J Biol Chem; 1999 Apr; 274(14):9503-8. PubMed ID: 10092634
[TBL] [Abstract][Full Text] [Related]
28. Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements.
Brandt S; Shafikhani S; Balachandran P; Jin S; Hartig R; König W; Engel J; Backert S
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):190-205. PubMed ID: 17428306
[TBL] [Abstract][Full Text] [Related]
29. Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa.
Masters SC; Pederson KJ; Zhang L; Barbieri JT; Fu H
Biochemistry; 1999 Apr; 38(16):5216-21. PubMed ID: 10213629
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells.
Heimer SR; Evans DJ; Stern ME; Barbieri JT; Yahr T; Fleiszig SM
PLoS One; 2013; 8(9):e73111. PubMed ID: 24058462
[TBL] [Abstract][Full Text] [Related]
31. ADP ribosylation of Arg41 of Rap by ExoS inhibits the ability of Rap to interact with its guanine nucleotide exchange factor, C3G.
Riese MJ; Wittinghofer A; Barbieri JT
Biochemistry; 2001 Mar; 40(11):3289-94. PubMed ID: 11258948
[TBL] [Abstract][Full Text] [Related]
32. Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS.
Hritonenko V; Evans DJ; Fleiszig SM
Microbes Infect; 2012 Dec; 14(15):1366-73. PubMed ID: 22981600
[TBL] [Abstract][Full Text] [Related]
33. The GAP portion of Pseudomonas aeruginosa type III secreted toxin ExoS upregulates total and surface levels of wild type CFTR.
Tukaye DN; Kwon SH; Guggino WB
Cell Physiol Biochem; 2013; 31(1):153-65. PubMed ID: 23428533
[TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa injects type III effector ExoS into epithelial cells through the function of type IV pili.
Hayashi N; Nishizawa H; Kitao S; Deguchi S; Nakamura T; Fujimoto A; Shikata M; Gotoh N
FEBS Lett; 2015 Apr; 589(8):890-6. PubMed ID: 25747138
[TBL] [Abstract][Full Text] [Related]
35. ADP-ribosylation of oncogenic Ras proteins by pseudomonas aeruginosa exoenzyme S in vivo.
Vincent TS; Fraylick JE; McGuffie EM; Olson JC
Mol Microbiol; 1999 Jun; 32(5):1054-64. PubMed ID: 10361307
[TBL] [Abstract][Full Text] [Related]
36. Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells.
Pederson KJ; Pal S; Vallis AJ; Frank DW; Barbieri JT
Mol Microbiol; 2000 Jul; 37(2):287-99. PubMed ID: 10931325
[TBL] [Abstract][Full Text] [Related]
37. Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.
Rocha CL; Rucks EA; Vincent DM; Olson JC
Infect Immun; 2005 Sep; 73(9):5458-67. PubMed ID: 16113262
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites.
Ganesan AK; Frank DW; Misra RP; Schmidt G; Barbieri JT
J Biol Chem; 1998 Mar; 273(13):7332-7. PubMed ID: 9516428
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.
Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M
Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339
[TBL] [Abstract][Full Text] [Related]
40. ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA.
Fraylick JE; Riese MJ; Vincent TS; Barbieri JT; Olson JC
Biochemistry; 2002 Jul; 41(30):9680-7. PubMed ID: 12135390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
